By Devika Patel
Knoxville, Tenn., Oct. 7 - ARYx Therapeutics, Inc. said it has arranged a $35 million two-year committed equity financing facility with Commerce Court Small Cap Value Fund, Ltd.
The company may sell shares to Commerce at pre-negotiated discounts determined by a formula.
Reedland Capital Partners is the agent.
Proceeds will be used for general corporate purposes.
Based in Fremont, Calif., ARYx Therapeutics is a biopharmaceutical company.
| Issuer: | ARYx Therapeutics, Inc.
|
| Issue: | Committed equity financing facility
|
| Amount: | $35 million
|
| Tenor: | Two years
|
| Warrants: | No
|
| Agent: | Reedland Capital Partners
|
| Investor: | Commerce Court Small Cap Value Fund, Ltd.
|
| Settlement date: | Oct. 7
|
| Stock symbol: | Nasdaq: ARYX
|
| Stock price: | $3.13 at close Oct. 6
|
| Market capitalization: | $86.2 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
